Commodity Description:
MIXED SHIPMENTS of Two or More of The Following
PHARMACEUTICALS, VIZ: Escitalopram; Ondansetron
Orally Disintegrating Tablets; Losartan Potassium Tablets;
Metoprolol Tartrate Tablets; Pantoprazole Tablets;
Metformin Tablets; Glyburide and Metformin Hydrochloride
Tablets; Finasteride Tablets; Fluoxetine Capsules;
Montelukast Sodium Chewable Tablets; and/or Valsartan
and Hydrochloride Thiazide Tablets; Pioglitazone
Hydrochloride and Metformin Hydrochloride Tablets;
Alendronate Sodium Tablets; Ondansetron HCL Tablets,
Naproxen Sodium Tablets; Extended Phenytoin Sodium
Capsules; Sertraline Hydrochloride Tablets; Abacavir
Sulfate Tablets; Amlodipine Besylate/Benzazepril
Hydrochloride Capsules; Ciprofloxacin Tablets; Carvedilol
Tablets; Fosinopril Sodium and Hydrochloro Thiazide
Tablets; Levetiracetam Tablets; Ramipril Capsules;
Venlafaxine Hydrochloride Extended Release Capsules;
Sulfamethoxazole and Trimethoprim Oral Suspensions;
Ribavirin Capsules; Lamotrigine Tablets, Aripiprazole
Orion; Quinapril Tablets; Celecoxib Capsules;
Sulfamethoxazole and Trimethoprim Tablets; Sertraline
Hydrochloride Tablets; Ibandronate Sodium Tablets;
Paricalcitol Capsules; Lamivudine Tablets; Perindopril
Tablets; Clarithromycin Tablets; Rizatriptan Tablets;
Divalproex Sodium Extended-Release Tablets;
Clozapine Tablets; Amlodipine and Valsartan Tablets;
Losartan Potassium and Hydrochlorothizide Tablets;
Sumatriptan Succinate Tablets; Telmisartan Tablets;
Tamsulosin Hydrochloride Capsules; Escitalopram
Tablets; Didanosine Delayed Release Capsules;
Gabapentin Capsules; Zolmitriptan Tablets; Olanzapine
Orally Disintegrating Tablets; and/or Repaglinide
Tablets, N.O.S.
| Effective | 23FEB2017 |
|---|---|
| Filed | 23FEB2017 |
| Filing Codes | CR |
TLIs (Listed By Origin/Destination):